Price Alert

Sunshine Biopharma Inc. (SBFM)

NASDAQ: SBFM · Real-Time Price · USD

1.41

-0.01 (-0.70%)

At close: Aug 20, 2025, 12:06 PM

Sunshine Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	10.31M	8.12M	9.69M	12.21M	11.51M	17.43M	16.29M	18.85M	19.73M	19.29M	21.83M	40.56M	41.73M	13.18M	2.05M	2.39M	1.74M	1.8M
Short-Term Investments	n/a	70.46K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.59K	7.59K	7.59K	7.59K	7.59K	7.59K	7.59K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.31M	n/a	-1.93M	-3.77K	-1.64K	n/a	n/a	n/a	n/a	n/a
Receivables	3.59M	3.45M	3.87M	3.22M	3.97M	2.83M	2.55M	2.03M	2.01M	1.79M	1.91M	22.00	24.00	24.00	7.8K	1.13K	n/a	n/a
Inventory	13.02M	11.86M	11.28M	9.82M	8.49M	7.7M	5.73M	4.52M	4.25M	3.71M	3.29M	269.64K	205.37K	181.5K	105.65K	71.31K	45.22K	26.66K
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.59K	n/a	n/a	7.59K	7.59K	7.59K	n/a
Total Current Assets	27.85M	24.48M	25.97M	25.98M	25.75M	28.83M	24.89M	25.43M	26.1M	24.95M	27.31M	40.86M	41.99M	13.41M	2.2M	2.49M	1.8M	1.84M
Property-Plant & Equipment	1.53M	1.42M	1.48M	1.13M	1.11M	1M	1.01M	999.22K	1.08M	1.1M	1.15M	3.77K	1.64K	3.98K	7.06K	10.23K	13.48K	16.63K
Goodwill & Intangibles	2.49M	3.19M	3.02M	2.94M	2.45M	2.07M	1.44M	1.22M	1.23M	948.24K	776.86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.11M	4.71M	4.59M	4.07M	3.55M	3.07M	2.46M	2.22M	2.31M	2.04M	1.93M	3.77K	1.64K	3.98K	7.06K	10.23K	13.48K	16.63K
Total Assets	31.97M	29.19M	30.56M	30.06M	29.3M	31.9M	27.35M	27.65M	28.41M	26.99M	29.24M	40.86M	41.99M	13.41M	2.2M	2.5M	1.82M	1.86M
Account Payables	4.8M	5.02M	5.54M	4.16M	4.93M	3.62M	2.59M	2.22M	1.76M	2.74M	2.8M	480.21K	104.68K	95.23K	42.94K	56.69K	103.19K	148.56K
Deferred Revenue	n/a	n/a	n/a	n/a	-114.45K	254.97K	299.87K	-2.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	222.5K	213.98K	207.76K	116.25K	n/a	n/a	n/a	n/a	n/a	n/a	3.63M	n/a	n/a	n/a	n/a	330K	473.66K	664.69K
Other Current Liabilities	-222.5K	-213.98K	88.04K	-116.25K	254.97K	2.55M	2.85M	2.75M	2.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	5.57M	5.76M	6.31M	4.53M	5.3M	6.53M	5.55M	5.09M	4.66M	6.91M	6.93M	480.21K	104.68K	95.23K	91.23K	471.63K	635.56K	864.79K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.9M	3.2M	2.05M	2.08M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	706.53K	722.2K	744.72K	489.03K	511.63K	545.7K	587.76K	598.72K	639.88K	656.17K	685.26K	480.21K	104.68K	95.23K	1.9M	3.2M	2.05M	2.08M
Total Liabilities	6.28M	6.48M	7.06M	5.02M	5.81M	7.08M	6.14M	5.69M	5.3M	7.56M	7.62M	480.21K	104.68K	95.23K	1.99M	3.68M	2.69M	2.94M
Total Debt	929.03K	936.18K	952.48K	556.55K	577.36K	612.37K	657.71K	673.53K	719K	734.44K	4.27M	n/a	n/a	n/a	1.9M	3.53M	2.53M	2.74M
Common Stock	4.55K	2.71K	2.58K	2K	1.17K	995.00	28.02K	25.68K	25.75K	22.14K	22.59K	18.89K	18.89K	7.15K	2.59K	510.09K	486.09K	465K
Retained Earnings	-71.99M	-70.22M	-69.04M	-66.88M	-65.68M	-65.19M	-63.91M	-62.66M	-62M	-61.1M	-59.4M	-35.89M	-34.43M	-33.89M	-32.66M	-33.32M	-29.28M	-26.4M
Comprehensive Income	280.79K	-803.77K	-829.96K	168.59K	-683.05K	152.4K	696.11K	204.55K	665.06K	173.01K	161.85K	-79.9K	-34.78K	-22.13K	-23.14K	-17.48K	-11.64K	-4.93K
Shareholders Equity	25.68M	22.7M	23.5M	25.04M	23.49M	24.82M	21.21M	21.96M	23.11M	19.43M	21.63M	40.38M	41.89M	13.31M	211.66K	-1.17M	-872.71K	-1.08M
Total Investments	n/a	70.46K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.63M	7.59K	7.59K	7.59K	7.59K	7.59K	7.59K	7.59K